Lonza: Lonza joins CMAC to enhance service offering for specialty, enhanced drug product and particle technologies
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
Read full article »
Lonza is a Switzerland-based healthcare manufacturing firm that operates businesses in biologics, small molecules, cell and gene and capsules and health ingredients divisions.
Read more